We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.87%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOMD icon
1176
Nomad Foods
NOMD
$1.54B
$821K ﹤0.01%
49,835
AFG icon
1177
American Financial Group
AFG
$11.9B
$820K ﹤0.01%
6,666
-497
-7% -$64K
MAT icon
1178
Mattel
MAT
$3.76B
$816K ﹤0.01%
50,169
+3,662
+8% +$66.4K
DINO icon
1179
HF Sinclair
DINO
$20.3B
$813K ﹤0.01%
15,251
-4,458
-23% -$251K
TKO icon
1180
TKO Group
TKO
$14.1B
$813K ﹤0.01%
7,525
+2,718
+57% +$276K
NKE icon
1181
Nike
NKE
$53.1B
$810K ﹤0.01%
10,745
-297
-3% -$27.6K
FLGT icon
1182
Fulgent Genetics
FLGT
$595M
$804K ﹤0.01%
40,981
+3,374
+9% +$70.4K
NKTX icon
1183
Nkarta
NKTX
$206M
$802K ﹤0.01%
135,749
+135,274
+28,479% +$957K
RBC icon
1184
RBC Bearings
RBC
$15.4B
$797K ﹤0.01%
2,954
-359
-11% -$96.4K
LADR
1185
Ladder Capital
LADR
$1.21B
$795K ﹤0.01%
70,455
-66,911
-49% -$734K
CBRE icon
1186
CBRE Group
CBRE
$40.1B
$791K ﹤0.01%
8,879
+4,665
+111% +$414K
AMPY icon
1187
Amplify Energy
AMPY
$189M
$789K ﹤0.01%
116,390
-966
-0.8% -$6.36K
ALV icon
1188
Autoliv
ALV
$8.49B
$788K ﹤0.01%
7,361
-526
-7% -$62.6K
GMED icon
1189
Globus Medical
GMED
$10.1B
$783K ﹤0.01%
11,437
-1,863
-14% -$111K
CG icon
1190
Carlyle Group
CG
$14.3B
$776K ﹤0.01%
19,320
-1,397
-7% -$60.3K
CYRX icon
1191
CryoPort
CYRX
$836M
$774K ﹤0.01%
+112,030
New +$1.51M
CTVA icon
1192
Corteva
CTVA
$54B
$774K ﹤0.01%
14,350
+2,392
+20% +$132K
AZEK
1193
DELISTED
The AZEK Co
AZEK
$773K ﹤0.01%
18,353
+14,160
+338% +$655K
LRN icon
1194
Stride
LRN
$3.41B
$768K ﹤0.01%
10,899
MGM icon
1195
MGM Resorts International
MGM
$9.66B
$768K ﹤0.01%
17,287
+100
+0.6% +$4.18K
CELH icon
1196
Celsius Holdings
CELH
$7.15B
$768K ﹤0.01%
13,444
-1,391
-9% -$105K
ATEN icon
1197
A10 Networks
ATEN
$1.93B
$766K ﹤0.01%
55,307
+98
+0.2% +$1.4K
VFC icon
1198
VF Corp
VFC
$5B
$763K ﹤0.01%
56,484
-6,229
-10% -$81.7K
BRX icon
1199
Brixmor Property Group
BRX
$8.59B
$761K ﹤0.01%
32,955
+1,058
+3% +$23.4K
CVBF icon
1200
CVB Financial
CVBF
$4B
$754K ﹤0.01%
43,729
-455
-1% -$7.58K

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.